XML 39 R2.htm IDEA: XBRL DOCUMENT v3.2.0.727
CHINA GEWANG BIOTECHNOLOGY, INC.- Balance Sheets - USD ($)
May. 31, 2015
Nov. 30, 2014
Current Assets:    
Cash $ 3,474,814 $ 3,012,812
Accounts receivable 222,905 0
Inventory, net 100,440 53,996
Prepaid expenses 140,601 105,200
Total current assets 3,938,760 3,172,008
Property, plant and equipment, net 58,819 48,184
Total Assets 3,997,579 3,220,192
Current Liabilities:    
Advance from customer   53,930
Accounts payable   7,225
Taxes payable 61,237 47,329
Payroll payable 48,990  
Accrued expenses and other payable 29,902 3,839
Loans from stockholder 44,523 6,417
TOTAL CURRENT LIABILITIES 184,652 121,740
Stockholders' equity:    
Common stock [1] 45,500 35,500
Additional paid-in capital 6,525,743 1,539,275
Less: subscriptions receivable (5,000,000)  
Retained earnings 1,925,314 1,316,225
Statutory reserve fund 215,737 144,454
Other comprehensive income 68,278 62,998
Sub-total 3,780,572 3,098,452
Non-controlling interest 32,355  
Total Stockholders' equity 3,812,927 3,098,452
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,997,579 $ 3,220,192
[1] $0.001 par value, 75,000,000 shares authorized; 45,500,000 shares issued and outstanding as of May 31, 2015 and 35,500,000 shares issued and outstanding as of November 30, 2014.